The percentage of technically satisfactory Pap tests, from women with a cervix, reported as including an endocervical component was as follows:
Year Quarter % with an Endocervical Component
2006 1st 76.9%
2nd 76.8%
3rd 77.5%
4th 77.5%
2007 1st 76.7%
2nd 76.9%
3rd 76.7%
4th 76.1%
2008 1st 75.8%
2nd 76.0%
3rd 76.2%
4th 75.8%
2009 1st 75.6%
2nd 75.8%
3rd 76.2%
4th 75.8%
2010 1st 75.1%
2nd 75.3%
3rd 75.2%
4th 74.3%
2011 1st 74.4%
2nd 74.9%
3rd 74.5%
4th 73.4%
2012 1st 73.6%
2nd 73.9%
3rd 73.8%
4th 73.0%
2013 1st 72.8%
2nd 72.4%
3rd 72.5%
4th 71.9%
2014 1st 72.1%
  2nd 72.3%
  3rd 72.5%
   4th 71.8%
 2015  1st 71.1%
   2nd 71.0%
   3rd 70.3%
   4th 69.7%
2016 1st 69.9%
  2nd 70.7%
  3rd 70.2%
  4th 69.8%
2017 1st 69.5%
  2nd 66.5%
  3rd 64.9%
• Compass HPV DNA tests are not relevant to the data in the above table.


The decline in the proportion of Pap tests with an endocervical component over time is statistically significant when comparing data for the calendar years of 2011 and 2016. Over this five year period the proportion of Pap tests with an endocervical component declined in 2011 from 74.3% (95%CI 74.2%-74.4%) to 70.1% (95%CI 70.0%-70.3%) in 2016 (p<0.001).
No national standards have been set in relation to the proportion of Pap tests that should include an endocervical component.